FFA
RDY icon

Farther Finance Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Farther Finance Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Sell
13,515
-1,760
-12% -$24.5K ﹤0.01% 2080
2025
Q4 		$214K Buy
15,275
+11,707
+328% +$164K ﹤0.01% 1874
2025
Q3 		$49.9K Buy
3,568
+2,444
+217% +$35.2K ﹤0.01% 2445
2025
Q2 		$16.9K Sell
1,124
-1,546
-58% -$22.1K ﹤0.01% 2784
2025
Q1 		$35.1K Buy
2,670
+123
+5% +$1.7K ﹤0.01% 2083
2024
Q4 		$40.2K Buy
2,547
+277
+12% +$4.16K ﹤0.01% 1770
2024
Q3 		$36.1K Buy
2,270
+685
+43% +$11K ﹤0.01% 1811
2024
Q2 		$23.9K Buy
1,585
+275
+21% +$3.94K ﹤0.01% 1726
2024
Q1 		$19.4K Sell
1,310
-1,900
-59% -$27.7K ﹤0.01% 1503
2023
Q4 		$44.7K Buy
3,210
+3,035
+1,734% +$40.6K ﹤0.01% 1075
2023
Q3 		$2.34K Buy
+175
New +$2.37K ﹤0.01% 1798

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Farther Finance Advisors's RDY Position: Q1 2026 in Review

Farther Finance Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 12% in Q1 2026, selling an estimated $24.5K and leaving 13,515 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Farther Finance Advisors first reported a position in RDY in Q3 2023 and has held it in 11 quarters since. The position peaked at $214K in Q4 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Farther Finance Advisors held 13,515 shares of Dr. Reddy's Laboratories worth $182K as of Q1 2026.
  • Farther Finance Advisors sold 1,760 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $24.5K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #2080 holding.
  • Farther Finance Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Dr. Reddy's Laboratories position peaked at $214K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.